Sarepta share price drops again after third gene therapy death
The death comes just as Sarepta has updated the label for Elevidys at the request of the FDA.
Explore our marketing solutions
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
